QuantuMDx
Newcastle upon Tyne, GB · 3 known investors
QuantuMDx develops point-of-care molecular diagnostics platforms and assays for detecting infectious diseases including sexually transmitted infections, antimicrobial resistance, respiratory viruses, and other pathogens. The company's Q-POC platform delivers rapid PCR test results in approximately 30 minutes for use in clinical, care home, and healthcare settings.
Founders & leadership
EW
Elaine WarburtonCo-Founder and former CEO
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- QUANTUMDX GROUP LIMITED
- Company number
- 06523152
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 4 Mar 2008
- Registered office
- Lugano Building, 57 Melbourne Street, Newcastle Upon Tyne, NE1 2JQ
- Nature of business (SIC)
- 86900 — Other human health activities
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 4 Mar 2026 · next due 18 Mar 2027
Current officers · 5
- John Burn — director, appointed 3 May 2010
- Xu Fan — director, appointed 11 Mar 2025
- Nisi Li — director, appointed 5 Sept 2024
- Jonathan James O'Halloran — director, appointed 4 Mar 2008
- Han Yan — director, appointed 21 Oct 2021
Source: Companies House public register · retrieved 6 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.